341 related articles for article (PubMed ID: 11272145)
1. Characterization of a KATP channel-independent pathway involved in potentiation of insulin secretion by efaroxan.
Chan SL; Mourtada M; Morgan NG
Diabetes; 2001 Feb; 50(2):340-7. PubMed ID: 11272145
[TBL] [Abstract][Full Text] [Related]
2. Essential role of the imidazoline moiety in the insulinotropic effect but not the KATP channel-blocking effect of imidazolines; a comparison of the effects of efaroxan and its imidazole analogue, KU14R.
Bleck C; Wienbergen A; Rustenbeck I
Diabetologia; 2005 Dec; 48(12):2567-75. PubMed ID: 16283242
[TBL] [Abstract][Full Text] [Related]
3. Clotrimazole and efaroxan stimulate insulin secretion by different mechanisms in rat pancreatic islets.
Chan SL; Pallett AL; Morgan NG
Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):763-8. PubMed ID: 9453462
[TBL] [Abstract][Full Text] [Related]
4. ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line.
Chapman JC; McClenaghan NH; Cosgrove KE; Hashmi MN; Shepherd RM; Giesberts AN; White SJ; Ammälä C; Flatt PR; Dunne MJ
Diabetes; 1999 Dec; 48(12):2349-57. PubMed ID: 10580423
[TBL] [Abstract][Full Text] [Related]
5. Effector systems involved in the insulin secretory responses to efaroxan and RX871024 in rat islets of Langerhans.
Mourtada M; Smith SA; Morgan NG
Eur J Pharmacol; 1998 Jun; 350(2-3):251-8. PubMed ID: 9696415
[TBL] [Abstract][Full Text] [Related]
6. Glucose dependence of imidazoline-induced insulin secretion: different characteristics of two ATP-Sensitive K+ channel-blocking compounds.
Bleck C; Wienbergen A; Rustenbeck I
Diabetes; 2004 Dec; 53 Suppl 3():S135-9. PubMed ID: 15561901
[TBL] [Abstract][Full Text] [Related]
7. The alpha 2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells.
Chan SL; Dunne MJ; Stillings MR; Morgan NG
Eur J Pharmacol; 1991 Oct; 204(1):41-8. PubMed ID: 1687123
[TBL] [Abstract][Full Text] [Related]
8. cAMP enhances insulin secretion by an action on the ATP-sensitive K+ channel-independent pathway of glucose signaling in rat pancreatic islets.
Yajima H; Komatsu M; Schermerhorn T; Aizawa T; Kaneko T; Nagai M; Sharp GW; Hashizume K
Diabetes; 1999 May; 48(5):1006-12. PubMed ID: 10331404
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.
Brown CA; Chan SL; Stillings MR; Smith SA; Morgan NG
Br J Pharmacol; 1993 Nov; 110(3):1017-22. PubMed ID: 7905338
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels.
Chan SL; Morgan NG
Eur J Pharmacol; 1990 Jan; 176(1):97-101. PubMed ID: 2178947
[TBL] [Abstract][Full Text] [Related]
11. Interactions between imidazoline compounds and sulphonylureas in the regulation of insulin secretion.
Mourtada M; Brown CA; Smith SA; Piercy V; Chan SL; Morgan NG
Br J Pharmacol; 1997 Jun; 121(4):799-805. PubMed ID: 9208151
[TBL] [Abstract][Full Text] [Related]
12. Evidence that the ability of imidazoline compounds to stimulate insulin secretion is not due to interaction with sigma receptors.
Chan SL; Pallett AL; Clews J; Ramsden CA; Morgan NG
Eur J Pharmacol; 1997 Apr; 323(2-3):241-4. PubMed ID: 9128845
[TBL] [Abstract][Full Text] [Related]
13. Multiple effector pathways regulate the insulin secretory response to the imidazoline RX871024 in isolated rat pancreatic islets.
Mourtada M; Chan SL; Smith SA; Morgan NG
Br J Pharmacol; 1999 Jul; 127(5):1279-87. PubMed ID: 10455276
[TBL] [Abstract][Full Text] [Related]
14. Elevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: implications for stimulus-response coupling of insulin release.
Shepherd RM; Hashmi MN; Kane C; Squires PE; Dunne MJ
Br J Pharmacol; 1996 Nov; 119(5):911-6. PubMed ID: 8922740
[TBL] [Abstract][Full Text] [Related]
15. Triggering of insulin release by a combination of cAMP signal and nutrients: an ATP-sensitive K+ channel-independent phenomenon.
Komatsu M; Sato Y; Yamada S; Yamauchi K; Hashizume K; Aizawa T
Diabetes; 2002 Feb; 51 Suppl 1():S29-32. PubMed ID: 11815454
[TBL] [Abstract][Full Text] [Related]
16. The role of cyclic AMP in the pathogenesis of glucose desensitization in rat pancreatic islets.
Yoshikawa H; Tajiri Y; Sako Y; Hashimoto T; Umeda F; Nawata H
Pancreas; 2001 May; 22(4):419-26. PubMed ID: 11345144
[TBL] [Abstract][Full Text] [Related]
17. Glucose triggers protein kinase A-dependent insulin secretion in mouse pancreatic islets through activation of the K+ATP channel-dependent pathway.
Thams P; Anwar MR; Capito K
Eur J Endocrinol; 2005 Apr; 152(4):671-7. PubMed ID: 15817925
[TBL] [Abstract][Full Text] [Related]
18. Effect of rise in cAMP levels on Ca2+ influx through voltage-dependent Ca2+ channels in HIT cells. Second-messenger synarchy in beta-cells.
Rajan AS; Hill RS; Boyd AE
Diabetes; 1989 Jul; 38(7):874-80. PubMed ID: 2472299
[TBL] [Abstract][Full Text] [Related]
19. BPDZ 154 activates adenosine 5'-triphosphate-sensitive potassium channels: in vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism.
Cosgrove KE; Antoine MH; Lee AT; Barnes PD; de Tullio P; Clayton P; McCloy R; De Lonlay P; Nihoul-Fékété C; Robert JJ; Saudubray JM; Rahier J; Lindley KJ; Hussain K; Aynsley-Green A; Pirotte B; Lebrun P; Dunne MJ
J Clin Endocrinol Metab; 2002 Nov; 87(11):4860-8. PubMed ID: 12414839
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of insulin secretion by the imidazoline alpha 2-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding site.
Chan SL; Brown CA; Morgan NG
Eur J Pharmacol; 1993 Jan; 230(3):375-8. PubMed ID: 8095024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
